| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/14/2011 | US20110086859 Alkyl substituted indoloquinoxalines |
| 04/14/2011 | US20110086858 Compounds for the Treatment of Hepatitis C |
| 04/14/2011 | US20110086857 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/14/2011 | US20110086856 Compositions useful as inhibitors of protein kinases |
| 04/14/2011 | US20110086855 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 04/14/2011 | US20110086854 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions |
| 04/14/2011 | US20110086853 Therapeutic Compounds |
| 04/14/2011 | US20110086852 Pharmaceutical compounds |
| 04/14/2011 | US20110086851 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases |
| 04/14/2011 | US20110086850 Radiosensitization of tumors with indazolpyrrolotriazines for radiotherapy |
| 04/14/2011 | US20110086849 novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and ause thereof |
| 04/14/2011 | US20110086847 Thiadiazole modulators of beta adrenergic receptor |
| 04/14/2011 | US20110086846 Azaindazole Compounds As CCR1 Receptor Antagonists |
| 04/14/2011 | US20110086845 Compositions and Methods for Treating Neurodegenerating Diseases |
| 04/14/2011 | US20110086844 Oral Solid Solution Formulation of a Poorly Water-Soluble Active Substance |
| 04/14/2011 | US20110086843 Thiazole Derivatives and Use Thereof |
| 04/14/2011 | US20110086842 Pyrimidines as PLK inhibitors |
| 04/14/2011 | US20110086841 N-9 substituted purine compounds, compositions and methods of use |
| 04/14/2011 | US20110086840 N-7 substituted purine and pyrazolopyrimine compounds, compositions and methods of use |
| 04/14/2011 | US20110086839 Compounds |
| 04/14/2011 | US20110086838 Novel compounds as cannabinoid receptor ligands |
| 04/14/2011 | US20110086837 Combinations of a pi3k inhibitor and a mek inhibitor |
| 04/14/2011 | US20110086836 Substituted Phenylpiperidine Derivatives As Melanocortin-4 Receptor Modulators |
| 04/14/2011 | US20110086835 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors |
| 04/14/2011 | US20110086834 Alkynyl alcohols as kinase inhibitors |
| 04/14/2011 | US20110086833 Methods for treating spinal muscular atrophy |
| 04/14/2011 | US20110086832 Novel compounds as cannabinoid receptor ligands |
| 04/14/2011 | US20110086831 Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack |
| 04/14/2011 | US20110086830 Metal complexes of n-heterocyclic carbenes |
| 04/14/2011 | US20110086829 Compositions and methods for treating obesity |
| 04/14/2011 | US20110086828 Treatment of alcohol abuse and alcoholism using modulators of neurosteroid binding sites on gabaa receptors |
| 04/14/2011 | US20110086827 Combination medicament |
| 04/14/2011 | US20110086826 Liposomal camptothecins and uses thereof |
| 04/14/2011 | US20110086825 Therapeutic vaginal emollient |
| 04/14/2011 | US20110086824 (20S,22E)-2-Methylene-19-Nor-22-Ene-1Alpha,25-Dihydroxyvitamin D3 |
| 04/14/2011 | US20110086822 Substituted Tetracycline Compounds |
| 04/14/2011 | US20110086821 Tetracycline Compounds for Treatment of Cryptosporidium Parvum Related Disorders |
| 04/14/2011 | US20110086820 Analgesic agent comprising cyclic phosphatidic acid derivative |
| 04/14/2011 | US20110086819 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 04/14/2011 | US20110086818 Methods, compositions, and kits for treating pain and pruritus |
| 04/14/2011 | US20110086817 Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria |
| 04/14/2011 | US20110086815 Novel compositions containing xanthohumol-cyclodextrin complexes |
| 04/14/2011 | US20110086814 Inhibiting e.sakazakii growth |
| 04/14/2011 | US20110086813 Compounds for treating bacterial infections |
| 04/14/2011 | US20110086812 Transition state sturcture of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases |
| 04/14/2011 | US20110086811 High-concentration rutin-containing drink |
| 04/14/2011 | US20110086810 HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d] PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE |
| 04/14/2011 | US20110086805 In vitro method for diagnosing skin cancer |
| 04/14/2011 | US20110086802 Methods to increase permeability of corneal epithelium and destabilize stromal collagen fibril network |
| 04/14/2011 | US20110086800 Screening method for predicting susceptibility to breast cancer |
| 04/14/2011 | US20110086797 Control of spore germination |
| 04/14/2011 | US20110086761 Compositions and methods to control oomycete fungal pathogens |
| 04/14/2011 | US20110086341 Fluorinated resorufin compounds and their application |
| 04/14/2011 | US20110086138 Bitter Alkaloid Containing Consumables Comprising Bitter Blockers |
| 04/14/2011 | US20110086119 Preparation for the relief of disease |
| 04/14/2011 | US20110086114 Nasal composition |
| 04/14/2011 | US20110086113 Cannabinoids in combination with non-cannabinoid chemotherapeutic agents (e.g. serm or alkylating agents) |
| 04/14/2011 | US20110086112 Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same |
| 04/14/2011 | US20110086111 Polymeric systems for the delivery of anticancer drugs |
| 04/14/2011 | US20110086110 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof |
| 04/14/2011 | US20110086109 Low ether compositions and delivery apparatus |
| 04/14/2011 | US20110086105 Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation |
| 04/14/2011 | US20110086104 Residual solvent extraction method and microparticles produced thereby |
| 04/14/2011 | US20110086103 Novel mandelate salt of fesoterodine |
| 04/14/2011 | US20110086102 Delayed release compositions |
| 04/14/2011 | US20110086100 Polyethylene Glycol Aerogels for Targeted Delivery of Pharmaceutical Drubs |
| 04/14/2011 | US20110086099 Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs |
| 04/14/2011 | US20110086098 Rapidly disintegrating gelatinous coated tablets |
| 04/14/2011 | US20110086096 Modified release 1- [ (3-hydroxy-adamant-1-ylamino)-acetyl] -pyrrolidine-2 (s) -carbonitrile formulation |
| 04/14/2011 | US20110086094 Capsule for the prevention of cardiovascular diseases |
| 04/14/2011 | US20110086093 Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
| 04/14/2011 | US20110086092 Pharmacuetical tablets containing a plurality of active ingredients |
| 04/14/2011 | US20110086091 Stable crystal modifications of dopc |
| 04/14/2011 | US20110086089 Use of p27kip1 for the prevention and treatment of heart failure |
| 04/14/2011 | US20110086088 Compositions and methods for treatment of mammalian skin |
| 04/14/2011 | US20110086087 Process and Formulation for Immunizing Fish in Aquaculture Systems |
| 04/14/2011 | US20110086086 Transdermal system for varenicline |
| 04/14/2011 | US20110086085 Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same |
| 04/14/2011 | US20110086084 Active Agent Containing Polymer Network Delivery Composition and Articles Using the Same |
| 04/14/2011 | US20110086082 Composition, system, and method for modulating release kinetics in implantable drug delivery devices by modifying drug solubility |
| 04/14/2011 | US20110086081 Coating system and method for drug elution management |
| 04/14/2011 | US20110086074 Combinations of niacin and an oxicam |
| 04/14/2011 | US20110086073 NANOMETER-SIZED PRODRUGS OF NSAIDs |
| 04/14/2011 | US20110086071 Pharmaceutical Compositions Comprising Terbinafine |
| 04/14/2011 | US20110086070 Orally disintegrating compositions of rhein or diacerein |
| 04/14/2011 | US20110086064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 04/14/2011 | US20110086063 Vaccines for prevention and treatment of addiction |
| 04/14/2011 | US20110086049 Receptor Modulators |
| 04/14/2011 | US20110086046 Treatment of MS with goat serum |
| 04/14/2011 | US20110086044 Compositions and Methods to Inhibit HPV Infection |
| 04/14/2011 | US20110086043 STAT5a AND ITS FUNCTIONAL TUMOR SUPPRESSOR ANALOGS FOR TREATMENT OF MALIGNANCIES EXPRESSING NPM/ALK AND OTHER ONCOGENIC KINASES |
| 04/14/2011 | US20110086042 Centrosomal Proteins, Nucleic Acids and Method of Use Thereof |
| 04/14/2011 | US20110086039 Methods of Treating Liver Fibrosis and Pre-Cirrhosis with Epidermal Growth Factor Receptor Inhibitors |
| 04/14/2011 | US20110086035 Immunotherapeutic methods and molecules |
| 04/14/2011 | US20110086034 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 04/14/2011 | US20110086023 Combination antihistamine medication |
| 04/14/2011 | US20110086021 Sclerostin and the inhibition of WNT signaling and bone formation |
| 04/14/2011 | US20110086006 HCV NS3-NS4 Protease Resistance Mutants |
| 04/14/2011 | US20110086001 Compliant biocompatible polymer compositions for medical uses |
| 04/14/2011 | US20110085999 Use of at least one (dihydro)jasmonic acid derivative for treating dry skin |